BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3118438)

  • 1. The direct mutagenicity of aflatoxin B1 and metabolites to Salmonella typhimurium: structure mutagenicity relationships and mechanisms of action.
    Yourtee DM; Kirk-Yourtee CL; Searles S
    Res Commun Chem Pathol Pharmacol; 1987 Jul; 57(1):55-76. PubMed ID: 3118438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereochemical effect in the mutagenicity of the aflatoxicols toward Salmonella typhimurium.
    Yourtee DM; Kirk-Yourtee CL; Searles S
    Life Sci; 1987 Oct; 41(15):1795-803. PubMed ID: 3309517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the mutagenic effect of a medium containing aflatoxin B1 as a result of the yeast activity].
    Borisenko AE; Mirskaia EE; Borisenko EG
    Gig Sanit; 1990 Dec; (12):45-7. PubMed ID: 2128746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative mutagenicity of palmotoxin Bo and aflatoxins B1 and M1.
    Uwaifo AO; Emerole GO; Bababunmi EA; Bassir O
    J Environ Pathol Toxicol; 1979; 2(4):1099-107. PubMed ID: 109559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative aflatoxin B1 mutagenesis of Salmonella typhimurium TA 100 in metabolic and photoactivation systems.
    Israel-Kalinsky H; Malca-Mor L; Stark AA
    Cancer Res; 1984 May; 44(5):1831-9. PubMed ID: 6424931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by specific antibodies of the mutagenicity of aflatoxin B1 in bacteria.
    Sizaret P; Malaveille C; Brun G; Aguelon AM; Toussaint G
    Oncodev Biol Med; 1982; 3(2-3):125-34. PubMed ID: 6812028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity of tetramic mycotoxin cyclopiazonic acid.
    Sorenson WG; Tucker JD; Simpson JP
    Appl Environ Microbiol; 1984 Jun; 47(6):1355-7. PubMed ID: 6430233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of butylated hydroxytoluene on the in vitro metabolism, DNA-binding and mutagenicity of aflatoxin B1 in the rat.
    Fukayama MY; Hsieh DP
    Food Chem Toxicol; 1984 May; 22(5):355-60. PubMed ID: 6427081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of mutagenic and antimutagenic activities of alpha-bisabolol in the Salmonella/microsome assay.
    Gomes-Carneiro MR; Dias DM; De-Oliveira AC; Paumgartten FJ
    Mutat Res; 2005 Aug; 585(1-2):105-12. PubMed ID: 15936245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism, covalent binding, and mutagenicity of aflatoxin B1 by liver extracts from rats of various ages.
    Jayaraj A; Hardwick JP; Diller TW; Richardson AG
    J Natl Cancer Inst; 1985 Jan; 74(1):95-103. PubMed ID: 3918213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reduced mutagenicity of aflatoxin B1 due to hydroxylation: observations on five Salmonella typhimurium tester strains.
    Uwaifo AO; Bababunmi EA
    Cancer Lett; 1979 Aug; 7(4):221-5. PubMed ID: 389414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promutagen activation in partially hepatectomized mice.
    Vandewaa EA; Barney CC; Gentile JM
    Toxicol Lett; 1982 Dec; 14(3-4):253-60. PubMed ID: 6820200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain differences in the metabolic activation of aflatoxin B1 in the rat.
    Plummer S; Boobis AR; Davies DS
    Xenobiotica; 1987 Feb; 17(2):199-208. PubMed ID: 3105188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of propolis and bee venom on the mutagenicity of some direct- and indirect-acting mutagens.
    Varanda EA; Monti R; Tavares DC
    Teratog Carcinog Mutagen; 1999; 19(6):403-13. PubMed ID: 10587410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of rates of enzymatic oxidation of aflatoxin B1, aflatoxin G1, and sterigmatocystin and activities of the epoxides in forming guanyl-N7 adducts and inducing different genetic responses.
    Baertschi SW; Raney KD; Shimada T; Harris TM; Guengerich FP
    Chem Res Toxicol; 1989; 2(2):114-2. PubMed ID: 2519710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the mutagenicity and antimutagenicity of beta-ionone in the Salmonella/microsome assay.
    Gomes-Carneiro MR; Dias DM; Paumgartten FJ
    Food Chem Toxicol; 2006 Apr; 44(4):522-7. PubMed ID: 16223554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of mutagenic activity of aflatoxins after UV-irradiation.
    Kleinwächter V; Koukalová B
    Acta Biol Med Ger; 1979; 38(9):1239-42. PubMed ID: 399142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity of aflatoxins related to their metabolism and carcinogenic potential.
    Wong JJ; Hsieh DP
    Proc Natl Acad Sci U S A; 1976 Jul; 73(7):2241-4. PubMed ID: 781672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.